Table 2.
Serum index | Group | 0 W | 2 W | 4 W | 10 W |
---|---|---|---|---|---|
RANKL (pg/mL) |
Con (15) |
187.2 ± 27.3 |
184.1 ± 29.6 |
189.6 ± 25.5 |
183.6 ± 23.7 |
CRF (15) |
178. 1 ± 29.2 |
181.3 ± 32.7 |
206.3 ± 38.4 |
305.4 ± 40.2a |
|
2%La (14) |
183.9 ± 25.9 |
179.8 ± 28.1 |
201.7 ± 31.2 |
278.3 ± 36.9a |
|
OPG (pg/mL) |
Con (15) |
1956.2 ± 117.3 |
1894.3 ± 106.4 |
1931.5 ± 104.9 |
1912. 3 ± 96.7 |
CRF (15) |
1922.1 ± 98.5 |
1976.3 ± 95.2 |
2335.4 ± 114.9a |
2722.4 ± 153.5a |
|
2%La (14) |
1943.4 ± 105.9 |
1962.6 ± 100.5 |
2248.7 ± 134.6a |
2584.1 ± 147.8a,b |
|
RANKL/OPG | Con (15) |
0.09 |
0.10 |
0.10 |
0.09 |
CRF (15) |
0.09 |
0.09 |
0.09 |
0.11 |
|
2%La (14) | 0.09 | 0.09 | 0.09 | 0.10 |
aP < 0.01 vs Control Group at the same point.
bP < 0.05 vs CRF Group at the same point.